Pediatric patients head-up-tilt-test with pharmacological challenge, it is safe?

García, Alan; Bustillos-García, Gabriela A; Rivera-Roodríguez, Leonardo.
Arch. cardiol. Méx ; 90(2): 163-172, Apr.-Jun. 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1131026

Documentos relacionados

  1. Pediatric patients' head-up-tilt-test with pharmacological challenge, it is safe?
  2. Pediatrics patients head-up tilt test with pharmacological challenge, it is safe?
  3. Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol.
  4. [Comparison of the use of isoproterenol or nitroglycerine during the Tilt test].
  5. Diagnosis and treatment of recurrent syncope in a middle-aged women.
  6. Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors.
  7. Electrocardiographic Patterns in Patients with Neurally Mediated Syncope.
  8. Comparison of pain-provoked versus standard 40-min tilt table test for the conformation of vasovagal syncope.
  9. Brain MRI and EEG overemployment in patients with vasovagal syncope: results from a tertiary syncope unit.
  10. Comparison of a shortened isosorbide dinitrate-potentiated head-up tilt testing with the conventional protocol: tolerance and diagnostic accuracy.